STERIS plc Quarterly Income Tax Expense (Benefit) in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
STERIS plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q3 2024.
  • STERIS plc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $43.5M, a 24.1% increase year-over-year.
  • STERIS plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $157M, a 18.1% increase year-over-year.
  • STERIS plc annual Income Tax Expense (Benefit) for 2023 was $150M, a 20.5% increase from 2022.
  • STERIS plc annual Income Tax Expense (Benefit) for 2022 was $124M, a 50.7% increase from 2021.
  • STERIS plc annual Income Tax Expense (Benefit) for 2021 was $82.3M, a 31.8% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $157M $43.5M +$8.45M +24.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $149M $35.3M -$890K -2.46% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $150M $37.3M +$16.1M +75.8% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-29
Q4 2023 $133M $41M +$465K +1.15% Oct 1, 2023 Dec 31, 2023 10-K 2024-05-29
Q3 2023 $133M $35.1M -$362K -1.02% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $133M $36.2M +$9.29M +34.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $124M $21.2M -$8.92M -29.6% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-29
Q4 2022 $133M $40.5M +$1.22M +3.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-05-29
Q3 2022 $132M $35.4M +$15.4M +77.2% Jul 1, 2022 Sep 30, 2022 10-K 2024-05-29
Q2 2022 $116M $26.9M +$34M Apr 1, 2022 Jun 30, 2022 10-K 2024-05-29
Q1 2022 $82.3M $30.1M -$18.8M -38.5% Jan 1, 2022 Mar 31, 2022 10-K 2024-05-29
Q4 2021 $101M $39.3M +$14.5M +58.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 $86.7M $20M -$7.8M -28.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $94.5M -$7.08M -$26.2M -137% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $121M $49M +$24.1M +97.3% Jan 1, 2021 Mar 31, 2021 10-K 2023-05-26
Q4 2020 $96.5M $24.8M -$4.44M -15.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $101M $27.8M +$5.61M +25.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $95.3M $19.1M +$4.45M +30.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $90.9M $24.8M +$400K +1.64% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-31
Q4 2019 $90.5M $29.3M +$20M +214% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $70.5M $22.2M +$4.4M +24.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $66.1M $14.6M +$1.86M +14.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $64.3M $24.4M Jan 1, 2019 Mar 31, 2019 10-K 2021-05-28
Q4 2018 $9.33M Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 $17.8M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $12.8M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.